InvestorsHub Logo
Followers 33
Posts 1917
Boards Moderated 1
Alias Born 08/02/2019

Re: loanranger post# 399943

Saturday, 10/21/2023 1:05:44 PM

Saturday, October 21, 2023 1:05:44 PM

Post# of 403047
This is more funny. Of course you want only to be provocative:

Are there any assets of value to sell


Brilacidin
3 successful Phase 2 human trials
3 different maladies
3 different administration method

You do not agree with my opinion?
"Brilacidin is now among our best options to fight antimicrobial resistant strains of bacterial infections, one of the scariest global threats,” explained Vincenzo Carnevale, professor of research at CST’s Institute for Computational Molecular Science (ICMS). He noted that the last truly novel class of antimicrobial molecules—not an optimization of preexisting molecules—was approved by the U.S. Food and Drug Administration in 1987."
https://news.temple.edu/news/2021-12-14/michael-l-klein-wins-prestigious-john-scott-award
There are many many other independent observations like this on Brilacidin value. An other independent positive opinion on Brilacidin value will arrive in Athens on Monday. Of course you know this.

Does Ipix have any assets of value?? Pfft
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C10&q=brilacidin&btnG=
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News